Manning & Napier Advisors’s Protalix BioTherapeutics PLX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-15,971
Closed -$784K 347
2013
Q2
$784K Buy
+15,971
New +$784K ﹤0.01% 312